Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis

Authors

Schepers, M., Paes, D., Tiane, A., Rombaut, B., Piccart, E., van Veggel, L., Gervois, P., Wolfs, E., Lambrichts, I., Brullo, C., Bruno, O., Fedele, E., Ricciarelli, R., Ffrench-Constant, C., Bechler, M.E., van Schaik, P., Baron, W., Lefevere, E., Wasner, K., Grunewald, A., Verfaillie, C., Baeten, P., Broux, B., Wieringa, P., Hellings, N., Prickaerts, J., Vanmierlo, T.

Journal

Brain Behavior and Immunity, 109, 1-22

Published

2023

These studies were carried out at the Stem Cell Institute Leuven (KU Leuven) by scientists who now work at ReWrite. All rights to this research belong to KU Leuven.